Shanghai Bio-heart Biological Technology Co., Ltd. (HKG:2185)
4.940
+0.180 (3.78%)
At close: Mar 10, 2026
HKG:2185 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Net Income | -89.33 | -87.94 | -175.89 | -204.24 | -361.45 | -325.52 | Upgrade
|
| Depreciation & Amortization | 11.81 | 8.05 | 21.27 | 20.86 | 13.23 | 8.64 | Upgrade
|
| Other Amortization | 0.12 | 0.12 | 0.09 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | 1.47 | 1.47 | 30.51 | 0 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 32.17 | 32.17 | -0.47 | - | - | - | Upgrade
|
| Loss (Gain) on Equity Investments | 0.58 | 0.99 | 1.63 | 1.43 | - | - | Upgrade
|
| Stock-Based Compensation | - | - | 47.63 | 140.48 | 318.72 | 268.12 | Upgrade
|
| Other Operating Activities | 2.18 | -7.34 | -19.5 | -50.63 | -42.05 | 1.21 | Upgrade
|
| Change in Inventory | -19.79 | -14.35 | -3.98 | - | - | - | Upgrade
|
| Change in Accounts Payable | 0 | 0.1 | - | -0.01 | - | 3.56 | Upgrade
|
| Change in Unearned Revenue | 17.94 | -0.6 | -0.92 | -0.98 | 1.37 | -1.75 | Upgrade
|
| Change in Other Net Operating Assets | 3.67 | -52.22 | 50.6 | -47.53 | -18.3 | -2.75 | Upgrade
|
| Operating Cash Flow | -51.33 | -119.55 | -49.03 | -140.62 | -88.47 | -48.49 | Upgrade
|
| Capital Expenditures | -27.55 | -47.14 | -17.72 | -30.04 | -34.27 | -5.75 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0.11 | - | - | - | Upgrade
|
| Cash Acquisitions | - | - | - | - | - | -220.42 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | -0.26 | - | -0.43 | - | Upgrade
|
| Investment in Securities | -157.8 | - | -15 | -74.66 | - | - | Upgrade
|
| Other Investing Activities | 0.67 | 1.11 | 4 | 4.01 | 0.97 | 1.01 | Upgrade
|
| Investing Cash Flow | -184.67 | -46.03 | -28.86 | -100.69 | -33.73 | -225.15 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | - | -5.35 | Upgrade
|
| Long-Term Debt Repaid | - | -2.12 | -5.26 | -3.59 | -4.29 | -1.17 | Upgrade
|
| Total Debt Repaid | -2.1 | -2.12 | -5.26 | -3.59 | -4.29 | -6.51 | Upgrade
|
| Net Debt Issued (Repaid) | -2.1 | -2.12 | -5.26 | -3.59 | -4.29 | -6.51 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 395.25 | 733.39 | Upgrade
|
| Repurchase of Common Stock | - | - | - | -29.44 | - | - | Upgrade
|
| Other Financing Activities | 152.41 | -0.32 | -0.56 | -2.15 | -7.27 | -3.88 | Upgrade
|
| Financing Cash Flow | 150.31 | -2.44 | -5.82 | -35.18 | 383.68 | 722.99 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.18 | 0.97 | 1.82 | 19.27 | -6.61 | -16.35 | Upgrade
|
| Net Cash Flow | -85.52 | -167.05 | -81.88 | -257.21 | 254.86 | 433 | Upgrade
|
| Free Cash Flow | -78.88 | -166.69 | -66.74 | -170.65 | -122.75 | -54.24 | Upgrade
|
| Free Cash Flow Per Share | -0.32 | -0.69 | -0.27 | -0.70 | -0.56 | -0.40 | Upgrade
|
| Levered Free Cash Flow | -58 | -134.87 | -3.8 | -77.41 | 26.76 | 66.45 | Upgrade
|
| Unlevered Free Cash Flow | -55.81 | -134.83 | -3.44 | -76.81 | 27.19 | 66.49 | Upgrade
|
| Change in Working Capital | -10.34 | -67.07 | 45.71 | -48.52 | -16.93 | -0.94 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.